Fragment BioTech
Jamie Davison possesses extensive experience in leadership and advisory roles across multiple companies. As Director at High Fives since March 2017, Jamie emphasizes the unique challenges of running a business. Jamie co-founded and serves as Non Executive Director at Carbon Group, which has expanded significantly since its 2014 launch. Additionally, Jamie holds multiple CFO, advisory, and investor positions at various innovative firms, including CoraMetix, Fragment BioTech, lubdub.ai, and VeinTech, focusing on advanced medical technologies and diagnostics. Other engagements include advisory roles at Timely Coffee and Peard Real Estate, along with investment interests in Bunsters and Yappy Group. Jamie's academic credentials include a Master of International Economics & Finance and participation in the CPA Program at prominent universities.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Fragment BioTech
With a new and rapid technology to measure biomarkers, carefully benchmarked against current gold standards, we seek to drive a disruptive shift in capability, access, and precision of biomarker data for screening and diagnostics. We aim to make Fragment synonymous with rapid biosensing.